Wingless and int homologue (Wnt) family proteins have been shown to have important roles in the decision of cell fate and behavior at multiple stages during the development and tumorigenesis. One of the Drosophila segment polarity genes, porcupine (porc) gene, encodes an evolutionarily conserved endoplasmic reticulum membrane protein involving in the post-translational processing of the Wnt family proteins. Here, we report that human homologue of Drosophila porc gene, PPN/MG61, was abundantly expressed in human cancer cell lines, but not in normal cells. We also found that PPN/MG61 was overexpressed in primary lung cancer tissue samples, compared to their matched normal tissue samples. Furthermore, when we used small interfering RNA to knock down PPN/MG61 mRNA in lung cancer cells expressing the gene, we observed apoptosis induction, along with decreased activity of Wnt pathway in those lung cancer cells. These data suggest that PPN/MG61 may be a novel marker for human lung cancer and that post-translational modification of the Wnt signal molecules by PPN/MG61 may be important for the function of Wnt pathway in lung cancer. Oncogene (2008) 27, 3483-3488; doi:10.1038/sj.onc.1211006 ; published online 14 January 2008
Keywords: lung cancer; PPN/MG61; apoptosis; wnt; diagnosis Mammalian Wingless and int homologue (Wnt) proteins comprise a family of 19 highly conserved and secreted glycoproteins of around 40 kDa with a high number of conserved cysteine residues (Miller, 2002) . Secreted Wnt ligands have been shown to activate signal transduction pathways and trigger changes in gene expression, cell behavior, adhesion and polarity. There are at least three pathways involving the Wnt signaling (Widelitz, 2005) . Among them, the best understood one is the so-called canonical pathway, in which Wnt ligands bind to two distinct families of cell-surface receptors: the Frizzled (Fz) receptor family and the LDL-receptor-related protein (LRP) family, and activate target genes through stabilization of b-catenin in the nucleus (Akiyama, 2000) . Wnt proteins can also signal through activating calmodulin kinase II and protein kinase C (known as the Wnt/Ca 2 þ pathway), or Jun N-terminal kinase (Veeman et al., 2003) .
One of the Drosophila segment polarity genes, porcupine (porc) encodes a multipass transmembrane endoplasmic reticulum (ER) protein, which is required for the normal distribution of Wingless (Wg) in embryos (Kadowaki et al., 1996; Thorpe et al., 1997) . Vertebrate homologues of porc have been shown to modify the N-glycosylation of Wg and mouse Wnt proteins in cultured cells (Tanaka et al., 2000 (Tanaka et al., , 2002 . It was found that cysteine palmitoylation is essential for the function of Wnt proteins (Willert et al., 2003) . Hofmann (2000) reported that Porc required in Wnt-secreting cells, shows homology to acyltransferases in the ER. Porc acylates Wnt proteins and anchors them at the ER membrane to stimulate their post-translational N-glycosylation, which is necessary for secretion. Furthermore, the human homologue of Drosophila porc (PPN/MG61) can modulate the activity of human Wnt7A in a TCF-responsive reporter assay (Caricasole et al., 2002) . Taken together, it appears that Porc may be the enzyme responsible for cysteine palmitoylation of the Wnt proteins (Zhai et al., 2004; Mikels and Nusse, 2006) . Wnt/b-catenin signaling promotes cell survival in various cell types. Aberrant activation of the Wnt signaling pathway is associated with a variety of human cancers (reviewed in numerous articles, such as Moon et al., 2004; Katoh, 2005; Reya and Clevers, 2005) . For example, overexpression of Wnt ligands plays important roles in aberrant activation of the Wnt signaling pathway in a number of cancer types, including head and neck carcinoma, lung cancer, colon cancer, sarcoma and others (Rhee et al., 2002; Weeraratna et al., 2002; He et al., 2004 He et al., , 2005 Mazieres et al., 2005a, b; Mikami et al., 2005) . However, the role of post-translational modification of the Wnt proteins in oncogenesis remains unclear.
To investigate whether PPN/MG61, the human homologue of the Drosophila Porc, plays an important role in aberrant activation of the Wnt signaling pathway in human lung cancer, we examined the PPN/MG61 expression as well as the relationship between PPN/ MG61 function and the canonical Wnt pathway in lung cancer cells.
Overexpression of PPN/MG61 in human lung cancer cell lines
We first used semiquantitative reverse transcription PCR (RT-PCR) to examine the PPN/MG61 expression at mRNA level in human lung cancer cell lines (Figure 1 , Table 1 ). We found that the PPN/MG61 gene was overexpressed in 9 out of 10 lung cancer cell lines (A549, H460, H838, H1703, H1299, H1650, A427, H1975, H322 and H358) that we examined. On the other hand, no PPN/MG61 expression was observed in the two normal lung cell lines (fibroblasts) that we tested. As aberrant overexpression of Wnt ligands has been reported in all these lung cancer cell lines before , our results suggest that there may be a significant correlation between the two events.
Overexpression of PPN/MG61 in primary human lung cancer tissue samples
To study whether our observations in the lung cancer cell lines have clinical relevance, we next used semiquantitative RT-PCR to examine the amount of PPN/ MG61 mRNA in human primary lung cancer tissue samples ( Figure 2 ). Total RNA was extracted from freshly resected lung cancer and autologous matched normal lung tissues of the same patients. Among all 24 tissue samples from lung cancer patients, we observed elevated PPN/MG61 expression in nearly all the tumor samples (22 out of 24), when compared to their matched normal lung tissues. In the case number 12, the PPN/ MG61 expression was detectable neither in cancerous nor in its matched normal tissue samples. On the other hand, no noticeable or little (case numbers 2, 9, 14 and 23) PPN/MG61 expression was detected in normal tissue samples in most cases that we examined. These data are consistent with our observations in the lung cancer cell lines. Further investigation is needed to explore the relationship between overexpression of PPN/MG61 and the progression of lung cancer.
siRNA targeting PPN/MG61 induces apoptosis and blocks the canonical Wnt signaling in human lung cancer cells Next, we studied the effects of inhibiting PPN/MG61 expression on the canonical Wnt signaling pathway as well as the cell survival in human lung cancer cells. PPN/ MG61-targeted small interfering RNA (siRNA) was used to silence the PPN/MG61 mRNA. We designed three different siRNAs to knock down PPN/MG61 mRNA, and found that all three siRNAs suppressed PPN/MG61 mRNA expression level, but at different degrees (data not shown). Then we select the most effective one (see Overexpression of PPN/MG61 in human normal and lung cancer cell lines. Two normal lung cell lines (fibroblasts) and 10 lung cancer cell lines (A549, H460, H838, H1703, H1299, H1650, A427, H1975, H322 and H358), labeled as 1-12 were obtained from China Center for Type Culture Collection. Total RNA was prepared using TRIzol reagent; cDNA was produced by using AMV reverse transcriptase and N9 random primers. The sequences of primers for amplifying PPN/MG61 and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are listed in Table 1 . GAPDH was used as internal control. PCR cycles were 35 cycles for PPN/MG61 and 20 cycles for GAPDH, of 94 1C for 15 s, 55 1C for 30 s and 72 1C for 30 s, followed by a final extension at 72 1C for 10 min. Reverse transcription PCR products were then analyzed on 1% agarose gel electrophoresis and stained with ethidium bromide. 
Upregulation of PPN/MG61 in lung cancer Z Chen et al cell apoptosis in those PPN/MG61 siRNA (100 nM for 4 days)-treated lung cancer cells, but not in the nonsilencing control siRNA (100 nM for 4 days)-treated ones ( Figure 3e ). To confirm this apoptotic induction effect, we also performed an active caspase-3/7 staining in A549 cells. After incubation with Hoechst 33342 and FAM-DEVD-FMK caspase-3/7 reagent, the cells treated with nonsilencing control siRNA (100 nM for 3 days) did not show any green fluorescence, and the chromatin uniformly distributed in the nuclear (Figure 3f ). However, the cells treated with PPN/MG61 siRNA (100 nM for 3 days) showed both bright condensed blue staining (indicated by red arrows) and green fluorescence (indicated by white arrows; Figure 3g ), indicating the nuclear morphology changes and positions of active caspase-3/7 in the cells, respectively. The chromatin condensation, which was a sign of cell apoptosis was observed ( Figure 3g ). Next, we quantified the apoptotic cells based on the nuclear changes (chromatin condensation and nuclear fragmentation) and found 16.5% apoptotic cells in PPN/MG61-knockdown A549 cells, but only 3.5% apoptotic cells in the control cells (Figure 3h ). In addition, we found that cytosolic level of cleaved caspase-3 (active form) was elevated in PPN/MG61-knockdown cells by using western blotting (Figure 3j, right) . Taken together, we confirmed that knocking down of PPN/MG61 induced apoptosis in human lung cancer cells. Next, to determine whether the apoptotic effects correlated with the inhibition of the canonical Wnt signaling, we analyzed the cytosolic level of its key downstream component, b-catenin and one of its downstream targeted genes, Survivin, one of its downstream targeted genes by western blotting to explore the effect of PPN/MG61 siRNA on Wnt/b-catenin signal transduction (Figure 3i ). We first confirmed by using semiquantitative RT-PCR that PPN/MG61 siRNA inhibited the PPN/MG61 expression in those lung cancer cell lines that expressed the gene, whereas the nonsilencing control siRNA had no effect. We found that both cytosolic b-catenin and Survivin were downregulated after the PPN/MG61-siRNA treatment in all lung cancer cell lines that we examined (Figure 3i ), indicating that PPN/MG61 functions as a positive regulator of the canonical Wnt/b-catenin signaling pathway in those lung cancer cells. Furthermore, the TCF/LEF transcriptional activity in PPN/MG61 siRNA-treated A549 cells (100 nM for 1 day) was decreased to approximately 65% of that in control cells (Figure 3j, left panel) . To further confirm the suppression of the Wnt signaling pathway by inhibition of PPN/MG61 expression, we examined a few other downstream genes of the canonical Wnt/ b-catenin signaling pathway, such as cyclinD1, frizzled 7, disheveled by using semiquantitative RT-PCR after siRNA treatment (100 nM for 4 days) in A549 cells. The cytosolic levels of cyclinD1 were also analyzed by using western blotting. We found that the cyclinD1, frizzled 7 and disheveled were downregulated after PPN/MG61 was knocked down (Figure 3j, right) . Therefore, our results suggest that PPN/MG61 may be functionally important for the aberrantly activated Wnt/b-catenin signaling pathway, which is critical for the antiapoptosis and survival of human lung cancer cells.
As a negative control of our experiments, we treated two normal lung fibroblast cell lines lacking the PPN/MG61 expression with the PPN/MG61 siRNA (Figure 4) . Little or no cell apoptosis was detected in these normal lung cells after the 100 nM PPN/MG61 siRNA treatment for 4 days when compared to the nonsilencing control siRNA (100 nM) treatments (Figure 4a ). Semiquantitative RT-PCR again confirmed no PPN/MG61 expression in those cells, regardless of the treatment with either PPN/MG61 or nonsilencing control siRNA (Figure 4b ). We also analyzed the level of cytosolic b-catenin and survivin by western blotting and confirmed that PPN/MG61 siRNA did not affect Wnt/b-catenin signal transduction (both normal cell lines did not express survivin) in these normal cells (Figure 4b ), consistent with our apoptosis analysis data. Taken together, our results indicate that inhibition of PPN/MG61 is selective for the lung cancer cells expressing the gene but not for normal lung cells lacking In this study, we reported, for the first time, that the human porc homologue PPN/MG61 was overexpressed in lung cancer cell lines, primary tissue samples of lung cancer patients, but not in the normal controls, suggesting its potential clinical implications as an appropriate marker for lung cancer detection. Furthermore, we have shown that PPN/MG61 overexpression is necessary for survival of lung cancer cells. PPN/ MG61-knockdown mRNA induced apoptosis and attenuated the canonical Wnt signaling in the lung cancer cells expressing the gene but not in normal cells lacking the PPN/MG61 expression. These data suggest that lipid modification of the Wnt signaling molecules by PPN/MG61 is likely important for the activation of the Wnt pathway in tumorigenesis. Recent study showed that potential tumor suppressor gene Wnt-7a mRNA expression was dramatically reduced in non-small cell 0 -AATTCTCCGAACGTGTCACGT-3 0 , which does not target any known mammalian gene) (panels a and c show A549 and H1703 cells, respectively) and PPN/MG61 siRNA (5 0 -AAGTTGTCACAAGCTGGAACC-3 0 ) treatment (panels b and d show A549 and H1703 cells, respectively). Before use, the lyophilized siRNA was dissolved in annealing buffer and reheated to 95 1C for 1 min followed by 1 h at 37 1C incubation. Cells were plated into six-well plates with fresh media without antibiotics 24 h before transfection using Lipofectin (Invitrogen, Eugene, OR, USA). After siRNA transfection, plates were incubated at 37 1C before further analysis. For western blot analysis, cytosolic proteins were boiled for 5 min and were separated on 4-15% gradient sodium dodecyl sulfate-polyacrylamide gels and transferred to immobilion-P (Millipore, Billerica, MA, USA) membranes. The membranes were then blocked with 5% nonfat milk and 0.1% Tween 20 in tris-buffered saline for 1 h at room temperature and followed by incubation with primary antibody (b-catenin, survivin, and b-actin; Sigma Chemical Co.) for 1 h at room temperature, washing in 5% nonfat milk and 0.1% Tween 20 in TBS for three 10-min periods, and incubation with a secondary antibody: horseradish peroxidase (HRP)-conjugated anti-rabbit or anti-mouse antibodies (Amersham Pharmacia Biotech, Buckinghamshire, UK) for 1 h at room temperature. After washing with 5% nonfat milk and 0.1% Tween 20 in TBS, antigen-antibody complexes were detected by ECL blotting analysis system (Amersham Pharmacia Biotech). (j) On the left, TOPFLASH assay showing TCF/LEF-dependent transcriptional activity after the PPN/MG61 siRNA treatment (100 nM for 1 day) in A549 cells. Procedures were the same as those described elsewhere . On the right, semiquantitative RT-PCR analysis of the Wnt downstream components and western blotting of cyclinD1 and the cleaved form (active) of caspase-3 after the PPN/MG61 siRNA treatment in A549 cells. Both RT-PCR and western blot were performed as described above in (i).Wnt; Wingless and int homologue. Upregulation of PPN/MG61 in lung cancer Z Chen et al lung cancer cell lines and primary tumors. (Winn et al., 2005) . Loss of the Wnt-7a expression in lung cancer excludes it as a target of PPN/MG61 function in lung cancer. On the other hand, well-known Wnt-1 and Wnt-2 oncogenes have been shown to be overexpressed in various human cancers, including lung cancer (Rhee et al., 2002; Weeraratna et al., 2002; He et al., 2004 He et al., , 2005 Mikami et al., 2005; Mazieres et al., 2005a, b) , and can be the targets of PPN/MG61 function. Taken together, overexpression of PPN/MG61 may promote post-translational modification of the oncogenic Wnt molecules and contributes to aberrant activation of the Wnt/b-catenin signaling pathway in human lung cancer. However, the detailed mechanisms of the PPN/MG61 function and post-translational modification of the Wnt proteins in human cancer still need to be elucidated. Our data also suggest that PPN/ MG61 could be one of the provocative therapeutic targets. Thus, inhibition of the PPN/MG61 acyltransferase enzyme activity may have possible implications in the treatment of human lung cancer. Further studies of the PPN/MG61 acyltransferase activity in lung cancer cells, especially in primary lung cancer tissue samples, are needed to confirm our observations. Screen or rational design of specific small molecule compounds to inhibit the PPN/MG61 enzyme activity may be an important strategy for seeking targeted therapeutics against the canonical Wnt pathway.
